Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 439085-51-5
2. Bta798
3. Vapendavir [inn]
4. 3-ethoxy-6-(2-(1-(6-methylpyridazin-3-yl)piperidin-4-yl)ethoxy)benzo[d]isoxazole
5. Q8lvl5z68h
6. Bta-798
7. 3-ethoxy-6-(2-(1-(6-methylpyridazin-3-yl)piperidin-4-yl)ethoxy)-1,2-benzoxazole
8. 3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole
9. 3-ethoxy-6-{2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy}-1,2-benzoxazole
10. Unii-q8lvl5z68h
11. Schembl423752
12. Chembl2062774
13. Dtxsid40195984
14. Glxc-25535
15. Bcp23992
16. Mfcd18633281
17. 1,2-benzisoxazole, 3-ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-
18. Hy-106254
19. Bta-798; Bta798; Bta 798
20. Cs-0025433
21. F18154
22. Q27287117
23. 3-ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-1,2-benzisoxazole
24. 3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)-4-piperidyl]ethoxy]-1,2-benzoxazole
25. 3-ethoxy-6-{2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy}-1,2-benzisoxazole
26. Bt8
| Molecular Weight | 382.5 g/mol |
|---|---|
| Molecular Formula | C21H26N4O3 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 382.20049070 g/mol |
| Monoisotopic Mass | 382.20049070 g/mol |
| Topological Polar Surface Area | 73.5 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 475 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in viral infection.
ABOUT THIS PAGE
88
PharmaCompass offers a list of Vapendavir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vapendavir manufacturer or Vapendavir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vapendavir manufacturer or Vapendavir supplier.
PharmaCompass also assists you with knowing the Vapendavir API Price utilized in the formulation of products. Vapendavir API Price is not always fixed or binding as the Vapendavir Price is obtained through a variety of data sources. The Vapendavir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vapendavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vapendavir, including repackagers and relabelers. The FDA regulates Vapendavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vapendavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vapendavir supplier is an individual or a company that provides Vapendavir active pharmaceutical ingredient (API) or Vapendavir finished formulations upon request. The Vapendavir suppliers may include Vapendavir API manufacturers, exporters, distributors and traders.
Vapendavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vapendavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vapendavir GMP manufacturer or Vapendavir GMP API supplier for your needs.
A Vapendavir CoA (Certificate of Analysis) is a formal document that attests to Vapendavir's compliance with Vapendavir specifications and serves as a tool for batch-level quality control.
Vapendavir CoA mostly includes findings from lab analyses of a specific batch. For each Vapendavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vapendavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Vapendavir EP), Vapendavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vapendavir USP).
